Screener
Generate Biomedicines, Inc. GENB Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Generate Biomedicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Generate Biomedicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336437
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Marketable securities | 322,056 | 99,848 |
| Restricted cash and cash equivalents (VIE) | — | 339 |
| Prepaid expenses and other current assets | 12,838 | 12,528 |
| Total current assets | 470,253 | 234,365 |
| Property and equipment, net | 27,305 | 29,151 |
| Operating lease right-of-use assets | 55,074 | 59,860 |
| Other assets | 9,058 | 6,806 |
| Total assets | $561,690 | $330,182 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Generate Biomedicines, Inc.'s total current assets?
- Generate Biomedicines, Inc. (GENB) reported total current assets of $470.25M in Q2 2026.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Generate Biomedicines, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude